MyCELLINKSupport servicesContact us English OUR PRODUCTS OUR SCIENCE YOUR RESEARCH OUR EVENTS OUR STORY SHOP Get a quote 0 OUR STORY As part of BICO, the world’s leading bioconvergence company, we offer premium bioinks, bioprinters and services that enable critical breakthroughs in 3D cell culturing, tissue engineering and drug development. BICO.COM REVIEWS Most user-friendly Bioprinter ever. Stina Simonsson Organization: University of Gothenburg Ease of use: After sales service: Value for money: Cellink Bio X Rating: 5 Application Area: Bioprinting to generate tissue/organ Very user-friendly technique, therefore all students in my lab can bioprint! Three printer heads can make the most complicated structures and cell combinations with fast speed, high quality and always reproducible results. I am so pleased about my BioX, can´t wait for the next version. I highly recommend this bioprinter. Review date: 2019-02-18 | Cellink Bio X MORE REVIEWS Keep up with the latest news by signing up to our newsletter SUBSCRIBE Contact us U.S. +1 (833) 235-5465 EU. +46 31-12 87 00 sales@cellink.com Navigation Our products Our science Your research Our events Our company Careers Privacy policyCookie policySite Map FacebookInstagramTwitterLinkedIn CELLINK 2021, All rights reserved.

FINANCIALS PRESS RELEASESFINANCINGSHAREHOLDERSGOVERNANCE BICO.COMEng Investor relations BICO’s Q3 report released on November 10, 2021 → Earnings call presentation → Bico by numbers NET SALES Q1-Q3, 2021 0 MUSD ORGANIC GROWTH Q1-Q3, 2021 0 % EMPLOYEES 0 + INSTRUMENTS IN THE FIELD 0 + PUBLICATIONS 0 + COUNTRIES 0 + News 11/25/21 BICO ranked top-three fastest-growing technology company in Sweden by Deloitte 11/24/21 CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing 11/17/21 BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors 11/17/21REGULATORY Bulletin from the extraordinary general meeting in BICO Group AB (publ) 11/16/21 Cellenion Announces Co-Marketing Agreement with Bruker to Deliver Advanced Solutions for Single Cell Mass Spectrometry-Based Proteomics Analysis Read more Financial reports 11/10/21 Interim report January-September (Q3) 2021 08/18/21 Interim report January-June (Q2) 2021 05/12/21 Interim report January-March (Q1) 2021 03/17/21 Annual report 2019/2020 02/25/21 Year-end report September-December 2019/2020 Read More Calendar 02/23/22 Year-end report 2021 03/16/22 Annual report 2021 04/26/22 Annual General Meeting 2022 Read more Business areas Subscribe and stay updated with the latest news! SUBSCRIBE FINANCIALS Reports overview Financial calendar ABOUT Contact Press releases Shareholders Corporate Governance POLICIES Privacy policy Whistleblower/speak up channel Internal code of conduct Supplier code of conduct BICO.COM COPYRIGHT © 2021 BICO - INVESTORS - All rights reserved.